| July 1 |
Biogen Idec and Acorda Therapeutics Announce Collaboration Agreement to Develop and Commercialize MS Therapy Fampridine-SR in Markets Outside the U.S. |
| July 1 |
Maxygen Announces Joint Venture with Astellas to Develop Protein Pharmaceuticals |
| July 1 |
CombinatoRx and Neuromed Sign Merger Agreement |
| July 1 |
Iressa (Gefitinib) Receives Marketing Authorisation for the Treatment of Non-Small Cell Lung Cancer in Europe |
| July 1 |
Eisai and Pfizer Decide not to Appeal NICE Decision and Call for an Expedited Review of Guidance for Alzheimer's Disease |
| July 1 |
Roche Launches Novel Program to Ease Tamiflu Access to Developing Economies |
| July 1 |
Pfizer Updates Chantix (varenicline) Labeling in the United States |
| July 1 |
Charles River Announces RMS Succession Plan and Organizational Enhancements |
| July 2 |
Bayer Files Patent Infringement Lawsuit Against Teva |
| July 2 |
Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Investment |
| July 2 |
Current Status of the Development Programs of New Indications and Formulations for Aricept for Enhancing Patient Value |
| July 2 |
GSK Further Extends its Product Portfolio in the Middle East and North Africa |
| July 2 |
Alcon Discontinues Development of Anecortave Acetate for Intraocular Pressure Reduction |
| July 6 |
Cougar Biotechnology Announces Successful Completion of Johnson & Johnson's Initial Tender Offer and Commencement of Subsequent Offering Period |
| July 6 |
Novo Nordisk's Victoza (liraglutide) Receives Marketing Authorisation in Europe (3 July 2009) |
| July 6 |
Grassley Asks Top Medical Journals About Ghostwriting |
| July 7 |
SDI Reports: Sanofi-aventis U.S. Joins Ranks of Merck and GlaxoSmithKline as Three Companies Most Respected by Pediatricians, According to SDI Pharmaceutical Company Image Study |
| July 7 |
European Prices of 170 Best-Selling Drugs Averaged 40 Percent Less Than U.S. Prices in 2008 |
| July 7 |
Caraco Pharmaceutical Laboratories, Ltd. Announces an Indefinite Reduction in its Workforce |
| July 7 |
Thallion Suspends Patient Enrollment of TLN-232 Metastatic Melanoma Trial Over Licensing Dispute |
| July 7 |
Teva Provides Update on Generic Ortho Tri-Cyclen Lo |
| July 7 |
NexMed Announces Decision for Anti-Fungal Product |
| July 8 |
Biogen Idec Receives Fast Track Designation from FDA for PEGylated Interferon Beta-1a for Relapsing Multiple Sclerosis |
| July 8 |
Verilogue Study of More Than 20,000 Real-Life Patient-Physician Interactions Reveals Patients' Top Health-Related Fears |
| July 8 |
Sermo Survey of US Physicians Indicates AMA No Longer Represents Them |
| July 8 |
12th Annual Survey on Consumer Reaction to DTC Advertising of Prescription Drugs Reveals: Nearly 50% of Online Consumers Report Health Videos a Top Resource |
| July 8 |
Japanese Ministry of Health approves Rasilez, a first-in-class direct renin inhibitor (DRI), for the treatment of high blood pressure |
| July 9 |
ICON Acquires Veeda Laboratories Limited |
| July 9 |
EU: Antitrust: Shortcomings in Pharmaceutical Sector Require Further Action |
| July 9 |
New Senate Biosimilars Proposal Would Jeopardize New Medical Advancements and Cures |
| July 9 |
NICE Upholds GSK Appeal for Advanced Breast Cancer Treatment, Tyverb (lapatinib) |
| July 9 |
WHO Grants Prequalification to Cervarix |
| July 9 |
MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration |
| July 9 |
Pfizer To Appeal Canadian Federal Court Decision On Company's Norvasc Patent |
| July 9 |
ratiopharm Canada wins important patent legal battle with Pfizer |
| July 10 |
Asmanex (Mometasone Furoate Dry Powder Inhaler) Now Approved in Japan for the Treatment of Bronchial Asthma in Adult Patients |
| July 10 |
Remeron Now Approved in Japan for the Treatment of Depression in Adult Patients |
| July 10 |
Forest Laboratories and H. Lundbeck A/S Enter Into Settlement Agreement With Sun and Caraco Related to Lexapro Patent Litigation |
| July 10 |
Caraco Pharmaceutical Laboratories, Ltd. Enters Into Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro (escitalopram oxalate) ANDA Patent Litigation |
| July 10 |
Sciele Pharma, a Shionogi Company, Terminates Agreement to Acquire Victory Pharma, Inc. |
| July 10 |
Alimta (pemetrexed for injection) First Agent Approved in Europe as Maintenance Therapy for Advanced, Nonsquamous Non-Small Cell Lung Cancer |
| July 13 |
Johnson & Johnson Completes Acquisition of Cougar Biotechnology |
| July 14 |
Oscient Pharmaceuticals Files Voluntary Petition for Relief Under Chapter 11 of the United States Bankruptcy Code |
| July 14 |
HHS Purchases Additional H1N1 Vaccine Ingredients |
| July 14 |
Indy Lights Racer Charlie Kimball Will Not Let Diabetes Slow Him Down |
| July 14 |
Wyeth's Prevenar 13* Receives First Approval |
| July 15 |
FDA Requires Labeling Change for Some Drugs Used to Prevent Rejection of Kidney Transplants |
| July 15 |
Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 |
| July 15 |
Hormone Therapy Use Associated With Increased Risk of Ovarian Cancer |
| July 15 |
Expert Statement Issued about Lantus Following Recent Publications in Diabetologia |
| July 15 |
FDA Sends Warning Letter to Apotex |
| July 15 |
Merck and Schering-Plough Resolve Previously Disclosed Investigation Under State Consumer Protection Statutes Related to VYTORIN(ezetimibe/simvastatin) and ZETIA (ezetimibe) |
| July 16 |
Baxter Reports Strong Second Quarter 2009 Financial Results and Raises Full-Year Outlook |
| July 16 |
Phillip A. Sharp to Retire from Biogen Idec Board |
| July 16 |
Biogen Idec Reports Second Quarter 2009 Results |
| July 16 |
Novartis Delivers Strong Operational Performance In The First Half Of 2009 Driven By Sustained Pharmaceuticals Innovation |
| July 16 |
PharmaTelevision Launches New Premium Content Service |
| July 17 |
Biopure Files Voluntary Petition for Relief Under Chapter 11 of the United States Bankruptcy Code |
| July 17 |
FDA Reviewing Preliminary Safety Information on Asthma Drug Xolair |
| July 17 |
Luna Innovations Files for Chapter 11 Reorganization |
| July 17 |
Tibotec Pharmaceuticals Announces Agreement to Develop and Commercialize a New Fixed-Dose Combination of TMC278 and Truvada With Gilead Sciences |
| July 17 |
Pro-Pharmaceuticals Prevails in Trade Secret Lawsuit |
| July 20 |
Pfizer Receives Approval From European Commission For Pending Acquisition Of Wyeth |
| July 21 |
Merck Announces Second-Quarter 2009 Financial Results |
| July 21 |
Schering-Plough Reports Financial Results for 2009 Second Quarter |
| July 21 |
Elan Reports Second Quarter 2009 Financial Results |
| July 21 |
FDA Approves Vaccine for 2009-2010 Seasonal Influenza |
| July 21 |
Forest Laboratories, Inc. Reports Fiscal First Quarter 2010 Earnings Per Share of $0.87 |
| July 21 |
EPIX Pharmaceuticals Assigns All of Its Assets for the Benefit of Creditors |
| July 21 |
Ontario, Canada Leading World-Class Research on New Cancer Drugs |
| July 22 |
DellaCamera Advised That Enzon Has Set July 24, 2009 as Record Date for Consent Solicitation |
| July 22 |
Pfizer Reports Second-Quarter 2009 Results; Increases Full-Year 2009 Adjusted Diluted EPS(1) Guidance |
| July 22 |
Gilead Sciences Announces Record Second Quarter 2009 Financial Results |
| July 22 |
Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance |
| July 22 |
SEC Charges Perry Corp. With Disclosure Violations in Vote Buying Scheme |
| July 22 |
Vaxine Wins Line Honours With World's First Human Swine Flu Vaccine |
| July 23 |
Bristol-Myers Squibb to Acquire Medarex |
| July 23 |
Alcon and AstraZeneca to Collaborate on Eye Drug Development |
| July 23 |
Large Pharmaceutical Firms Are Getting More Drugs Into Development While Terminating Unpromising Candidates |
| July 23 |
Excellent Performance Highlights Second Quarter for Bristol-Myers Squibb |
| July 23 |
Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance |
| July 23 |
Double-digit increase in sales, operating profit1 and Core EPS |
| July 23 |
JMI Launches Specialty, Professional and Social Networking Site for Pharmacy Industry |
| July 24 |
Q2/2009: Merck Revenues Remain Steady at ? 1.9 Billion |
| July 24 |
Teva and Ortho-McNeil-Janssen Settle Ortho Tri-Cyclen Lo Litigation |
| July 24 |
Schering-Plough Reports Proposed Settlement in Litigation Involving Planned Merger with Merck |
| July 24 |
Ambrilia Biopharma Inc.: Termination of Study 303 and Update On C2L Development |
| July 27 |
Medtronic and Abbott Laboratories Resolve Global Vascular Patent Disputes |
| July 27 |
Sanofi Pasteur Strengthens Vaccines Position in India Through the Control of Shantha Biotechnics via Mérieux Alliance |
| July 28 |
Good First Six Months In 2009 For Boehringer Ingelheim - Successful Products Spiriva®, Micardis And Flomax Secure Good Growth |
| July 28 |
Raptor Pharmaceuticals Corp. and TorreyPines Therapeutics, Inc. Announce Merger Agreement |
| July 28 |
Bristol-Myers Squibb Begins Tender Offer to Acquire Medarex, Inc. |
| July 28 |
Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO) |
| July 28 |
Mylan Reports That the FDA Determined That All Accusations Were Unfounded |
| July 28 |
NHLBI Stops Study Of Treatment For Pulmonary Hypertension In Patients With Sickle Cell Disease Due To Safety Concerns |
| July 28 |
Insmed Provides Update on Supply of Iplex |
| July 29 |
Sanofi-aventis Announces Second Quarter 2009 Results |
| July 29 |
Pfizer Announces Partnership With Shanghai Institutes For Biological Sciences For Drug Discovery Activities |
| July 29 |
Bayer robust in a difficult environment |
| July 30 |
Sanofi-aventis to Acquire Merck's Interest in Merial |
| July 30 |
H. Lundbeck A/S (DK) - Pipeline update - following an interim analysis the studies with bifeprunox for the treatment of schizophrenia is discontinued |
| July 30 |
Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009 |
| July 30 |
AstraZeneca PLC: Second Quarter And Half Year Results 2009 |
| July 30 |
Pfizer, Kano State Reach Settlement Of Trovan Cases |
| July 31 |
Accreditation Council for Continuing Medical Education Chief Executive Testifies at Senate Hearing |
| July 31 |
Genzyme Corporation (GENZ) Target of Investigation for Potential Securities Law Violations, Hagens Berman Announces |
| July 31 |
Lilly Announces Continued Commitment to Transparency with Faculty Registry |
| July 31 |
Genzyme Provides Update on Allston Landing Plant |
| July 31 |
Ligand and Organon Mutually Terminate Collaboration and License Agreement |
| July 31 |
Averion Announces Organizational Realignment |
